A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61P 27/02 (2006.01)
Patent
CA 2648223
This invention relates to the use of compounts that disrupt IL-I receptor interaction for the treatment and/or prevention of ophthalmic diseases or disorders in mammals, particularly humans.
Cette invention porte sur l'utilisation de composés qui interrompent l'interaction du récepteur de l'interleukine-1 (IL-1) pour le traitement et/ou la prévention de maladies ou troubles ophtalmiques chez le mammifère, en particulier chez l'homme.
Keating Mark Taylor
Markabi Olivier Sabri
Neuner-Jehle Martin
Scassellati-Sforzolini Baldo
Sue Yoo Dana
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Use of il-i antibodies for treating ophthalmic disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of il-i antibodies for treating ophthalmic disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of il-i antibodies for treating ophthalmic disorders will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1482728